Position in ELAN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$47,322,541
+$542,075 QoQ
Shares Held
1,922,899
-1.6% QoQ
Ownership
0.385%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 518 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $2,415,050,910 across 61 Drug Manufacturers - Specialty & Generic names. ELAN ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
6,398,674 | $1,078,432,506 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,981,234 | $236,524,202 | |
| 3 | ZTS |
Zoetis Inc.
|
2,624,825 | $188,619,917 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
4,766,781 | $165,264,292 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
275,358 | $149,197,220 | |
| 6 | VTRS |
Viatris Inc
|
7,322,267 | $116,277,595 | |
| 7 | HLN |
Haleon plc
|
10,824,395 | $100,991,599 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
699,229 | $77,572,458 |
All Filings in ELAN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,322,541 | 1,922,899 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $46,780,466 | 1,954,888 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $41,054,054 | 1,814,143 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $38,635,284 | 1,918,336 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $6,261,735 | 438,497 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $4,959,821 | 472,364 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $90,321,317 | 7,458,408 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $147,746,962 | 10,057,656 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $82,191,213 | 5,695,857 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $114,043,073 | 7,005,103 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $95,075,495 | 6,380,906 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $59,066,397 | 5,255,018 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $49,602,936 | 4,930,710 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $104,094,777 | 11,073,913 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $43,473,147 | 3,557,541 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $26,822,983 | 2,161,401 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $9,941,275 | 506,433 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $9,262,050 | 355,004 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $8,716,148 | 307,123 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $5,474,011 | 171,653 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $31,944,595 | 920,859 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $53,056,174 | 1,801,568 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $79,722,398 | 2,599,361 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $213,295,009 | 7,636,771 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $132,790,941 | 6,190,720 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $66,949,680 | 2,990,160 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||